SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
MOH clinical practice guidelines
وقد وُضعت هذه الإرشادات المعنونة "إرشادات بشأن مياه الشرب: إمدادات المياه الصغيرة" لتناول الاحتياجات والفرص المرتبطة
بإمدادات المياه الصغيرة وتيسير التحسين التد...ريجي نحو خدمات مياه شرب آمنة ومستدامة للجميع.
تستند هذه الإرشادات إلى التوصية الرئيسية الواردة في إرشادات منظمة الصحة العالمية بشأن جودة مياه الشرب وتوفّر إرشادات حول تطبيق هذه التوصية على إمدادات المياه صغيرة الحجم على وجه الخصوص.
تهدف هذه الإرشادات إلى مساعدة الحكومات والممارسين على تحسين سلامة مياه الشرب المقدمة من خلال الإمدادات الصغيرة.
more
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and service providers in (1) estimating the total commodity needs and costs for successful implementation... of national health program strategies and goals, (2) identifying the funding needs and gaps for procuring the required commodities, and (3) planning procurements and shipment delivery schedules to ensure a sustained and effective supply of health commodities.
The step-by-step approach to quantification presented in this guide is complemented by a set of product-specific companion pieces that include detailed instructions for forecasting consumption of antiretroviral drugs, HIV test kits, antimalarial drugs, and laboratory supplies.
more
The emergency Water, Sanitation and Hygiene Promotion (WASH) gap analysis project was funded by The Humanitarian Innovation Fund (HIF), a program managed by Enhancing Learning and Research for Humanitarian Assistance (ELRHA) in partnership with the Active Learning Network for Accountability and Per...formance in Humanitarian Action (ALNAP), and is a component of a larger initiative to identify and support innovations in emergency WASH. This paper gives an explanation of the background, methodology, and findings of the program.
more
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 2: How long should treatment with antidepressants continue in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Zika virus infection: update on the evidence for a causal link to congenital brain abnormalities and Guillain-Barré syndrome
Update 7 September 2016
Standard Treatment Guideline